Physician
Nephrology
Dr. Charles J. Diskin, MD
|
|
Give Review
Charles J. Diskin, MD practices Nephrology. He went to Perelman School of Medicine at the University of Pennsylvania. Charles J. Diskin, MD is also a published doctor. He has 101 paper published. The most recent paper is: An analysis of the effect of routine medications on hemodialysis vascular access survival. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Waardenburg Syndrome With Familial Unilateral Renal Agenesis: A New Syndrome Variant?
- Towards Erythropoietin Equations That Estimate Oxygen Delivery rather than Static Hemoglobin Targets.
- The prevalence and meaning of eosinophilia in renal Diseases on a nephrology consultation service.
- Can the combination of Calcium and parathormone levels above k/doqi guidelines be used as a marker of adynamic bone disease in African Americans?
- The promise of pentoxifylline and interference With the renin-angiotensin system in diabetic nephropathy.
- Beyond anemia: the clinical impact of the physiologic effects of erythropoietin.
- Heparin and biofilm: is this the risk factor for catheter-related sepsis?
- Heparin, biofilm, and catheter-related sepsis.
- The evolution of the fractional excretion of urea as a diagnostic tool in oliguric states.
- Immunology and the evaluation of risk factors for development of spontaneous bacterial peritonitis.
- Standards and precision of thought: what might Galbraith say?
- Acute renal failure due to a primary renal B-cell lymphoma.
- A hypothesis: can erythropoietin administration affect the severity of retinopathy in diabetic patients with renal Failure?
- Hitting the target but missing the goal? Hemoglobin targets versus oxygen delivery.
- Malignancy-related Hypercalcemia developing on a bisphosphonate but responding to calcitonin.
- Erythropoietin levels and androgens use: what is their relationship in the correction of anemia?
- Is it time to reexamine KDOQI aluminum guidelines?
- More on case 7-2006.
- Removal of methotrexate by peritoneal dialysis and hemodialysis in a single patient with end-stage renal Disease.
- Multiple mechanisms for abnormal selenium levels and vascular disease in renal Failure.
- R wave increases after hemodialysis revisited.
- A change of reason: medicine and the scientific revolution.
- Pharmacologic intervention to prevent hemodialysis vascular access thrombosis: the next generation of treatment?
- Analgesic use in hemodialysis patients: Osler at the bedside and computer-generated data.
- Lessons from single cell organisms: insights into the antimicrobial and toxic effects of peritoneal dialysate bases.
- Electrocardiographic R wave increases after hemodialysis: round III.
- Gustatory sweating recurring on peritoneal dialysis but resolving during periods of hemodialysis.
- de Ketham revisited: a modern-day urine wheel.
- Erythropoietin, haemoglobin, heart Failure, and mortality.
- Understanding the pathophysiology of hemodialysis access problems as a prelude to developing innovative therapies.
- Toward the optimal clinical use of the fraction excretion of solutes in oliguric azotemia.
- Catheter locks, heparin and biofilm: what is this the risk?
- Will the addition of pentoxifylline reduce proteinuria in patients With diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzym...
- The contribution of nutrition to the protective value of high plasma aldosterone concentrations in hemodialysis patients.
- CPK-MB isoenzymes in muscular dystrophy: 30 years later.
- The periodicity of vascular access thrombosis revisited: TIS the season.
- Minoxidil use in proteinuric renal Disease.
- Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients? An evaluation of various biofilm and traditional risk factors.
- An understanding of trace metal physiology as an aid to interpretation of clearance studies by artificial organs.
- Can Acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients?
- Is the timing of thallium injection in relation to hemodialysis treatments important?
- Hemoglobin targets versus oxygen delivery: is it time for a new paradigm?
- The role of the nephrologist in the treatment of lupus Nephritis.
- Effect of phosphate binders upon TSH and L-thyroxine dose in patients on thyroid replacement.
- Creatinine and glomerular filtration rate: evolution of an accommodation.
- Does the hyperfiltration of minoxidil result in increased Proteinuria and loss of renoprotection conferred by angiotensin inhibition?
- Recurrent metabolic alkalosis and elevated troponins after crack cocaine use in a hemodialysis patient.
- Creatinine and GFR: an imperfect marriage of convenience.
- Peritoneal dialysis in patients With liver cirrhosis and/or ascites.
- Massive increase in Proteinuria after the introduction of midodrine in an elderly patient-a case report.
- Looking backward: a review of the treatment of systemic lupus erythematosus in end-stage renal Disease after a quarter of century.
- Notes on angiotensin inhibition and vascular access survival: time for randomized controlled trials.
- Vascular access cannulation and the end of religion: is it time or our own human variables that determine success?
- Selenium binding proteins, renal Failure, graft rejection and intimal hyperplasia: Which are causes and which are effects?
- Observe and be guarded: the development and rupture of an abdominal aortic mycotic aneurysm in an afebrile hemodialysis patient With normal angiogram, and CT scan, and...
- The clinical significance of aldosterone in ESRD: Part II.
- Observations on therapeutic drug use and hemodialysis vascular access faliure.
- Doxycycline may reduce the incidence of aneurysms in haemodialysis vascular accesses.
- Paroxysmal nocturnal hemoglobinuria after chloramphenicol therapy.
- Recurrent hyponatremia after intrathecal methotrexate not related to antidiuretic hormone: is a natriuretic peptide activated?
- The transplant donor payment debate.
- Catheter-related sepsis in dialysis patients.
- Erythropoietin and retinopathy: the beginning of an understanding.
- Caution With selenium replacement.
- Creatine phosphokinase MB band in oculopharyngeal muscular dystrophy.
- Long-term selenium exposure.
- Subclavian vein thrombosis treated With recombinant tissue plasminogen activator.
- Fish oil to prevent intimal hyperplasia and access thrombosis.
- Time of administration of Calcium acetate and phosphate binding.
- AIDS-related complex by continuous ambulatory peritoneal dialysis.
- Pharmacokinetics of sulindac in ESRD.
- Plasma selenium levels in renal Failure.
- The long-term clinical course of systemic lupus erythematosus in end-stage renal Disease.
- Thallium-201 myocardial imaging in patients on Chronic hemodialysis.
- The protective value of protein and complement in ascitic fluid.
- Uric acid levels and Renal blood flow.
- Electrocardiographic changes following dialysis.
- Minidose heparin therapy. Treatment of Chronic intravascular coagulation syndrome.
- Efficacy of an attachable silver impregnated subcutaneous cuff for the prevention of catheter-associated infections in patients on Chronic maintenance hemodialysis.
- Immunologic defects of the peritoneum determine the bacteriology of peritonitis.
- Pharmacokinetics and dialyzability of sulindac and metabolites in patients with end-stage renal Failure.
- Pharmacologic intervention to prevent hemodialysis vascular access thrombosis.
- Effect of cholestyramine resin on single dose valproate pharmacokinetics.
- The periodicity of vascular access thrombosis.
- The importance of delay in cannulation after hemodialysis vascular access surgery.
- Effects of hand dominance and sleep side preference on hemodialysis vascular access survival.
- The importance of timing of surgery for hemodialysis vascular access thrombectomy.
- Edema, oncotic pressure, and free entropy: novel considerations for the treatment of edema through attention to thermodynamics.
- An analysis of the effect of routine medications on hemodialysis vascular access survival.
- Towards an understanding of oedema.
- Intravenous analgesic use in dialysis patients.
- Diagnosis of tuberous sclerosis in a patient who presented with polycystic Kidney disease.
- Surface tension, Proteinuria, and the urine bubbles of Hippocrates.
- Case report and review: is the tendency for Curvularia tubular obstruction significant in pathogenesis?
- The use of new concepts in vascular physiology and pharmacology to improve hemodialysis access outcomes.
- Trace elements in dialysis patients.
- Selenium in renal Failure patients.
- Pneumonia in multiple myeloma: a case report.
- The comparative benefits of the fractional excretion of urea and sodium in various azotemic oliguric states.
- Novel insights into the pathobiology of the vascular access - do they translate into improved care?
Schools
University Of Pennsylvania School Of Medicine
Brown University
Stanford University
Procedures Preformed
- Arteriovenostomy for Renal Dialysis
- Biopsy
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Calcium Metabolism Disorders
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Education
-
Stanford University -
Perelman School of Medicine at the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1023122983 | |
| NPPES Provider LastName | DISKIN | |
| NPPES Provider FirstName | CHARLES | |
| NPPES Provider ZIPCode | 368015442 | |
| NPPES Provider State | AL | |
| Specialty Description | Nephrology | |
| Total Claim Count | 961.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1023122983 |
| Last Name Of The Provider | DISKIN |
| First Name Of The Provider | CHARLES |
| View All |
Similar Doctors
|
|
Dr. Thomas J. Stokes Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Afu M. Abdul, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dimtcho V. Popov, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas B. Carter, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda M. Dansby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lautrec W. Radcliff, MD
This Doctor is OpenDoctor Recommended.
|